291 related articles for article (PubMed ID: 19894653)
1. Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations.
Medenecka B; Jelińska A; Zajac M; Bałdyka M; Juszkiewicz K; Oszczapowicz I
Acta Pol Pharm; 2009; 66(5):563-9. PubMed ID: 19894653
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the stability of doxorubicin and daunorubicin in solid state.
Cielecka-Piontek J; Jelińska A; Zajac M; Sobczak M; Bartold A; Oszczapowicz I
J Pharm Biomed Anal; 2009 Nov; 50(4):576-9. PubMed ID: 19195811
[TBL] [Abstract][Full Text] [Related]
3. Stability of epidoxorubicin in solid state.
Sobczak A; Jelińska A; Leśniewska M; Firlej A; Oszczapowicz I
J Pharm Biomed Anal; 2011 Mar; 54(4):869-72. PubMed ID: 21112717
[TBL] [Abstract][Full Text] [Related]
4. Stability of ceftriaxone disodium in Biotrakson and Tartriakson.
Zajac M; Jelińska A; Zalewski P
Acta Pol Pharm; 2005; 62(2):89-94. PubMed ID: 16161347
[TBL] [Abstract][Full Text] [Related]
5. Stability of [(N-morpholine)metylene]daunorubicin hydrochloride in solid state.
Zalewski P; Jelińska A; Prusinowska P; Cielecka-Piontek J; Krause A; Oszczapowicz I
Acta Pol Pharm; 2011; 68(5):759-63. PubMed ID: 21928722
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state.
Cielecka-Piontek J; Zajac M; Jelińska A
J Pharm Biomed Anal; 2008 Jan; 46(1):52-7. PubMed ID: 17936535
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cefaclor oral suspensions stability using reversed phase high performance liquid chromatography and antimicrobial diffusion methods.
Tarawneh KA; Halasah ZA; Khleifat AM; Batarseh MI; Khleifat KM; Al-Mustafa AH
Pak J Pharm Sci; 2011 Jul; 24(3):303-13. PubMed ID: 21715263
[TBL] [Abstract][Full Text] [Related]
8. Stability of ceftazidime pentahydrate in medicinal preparations Biotum and Ceftim.
Zajac M; Jelińska A; Sobczak A; Musiał W
Acta Pol Pharm; 2005; 62(1):11-5. PubMed ID: 16022488
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of degradation of enalapril maleate in dosage forms.
Stanisz B
Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
[TBL] [Abstract][Full Text] [Related]
10. Stability of aztreonam in AZACTAM.
Zajac M; Jelińska A; Cielecka-Piontek J; Oszczapowicz I
Farmaco; 2005; 60(6-7):599-603. PubMed ID: 15932754
[TBL] [Abstract][Full Text] [Related]
11. Stability of cefotaxime sodium in solid state.
Zajac M; Musiał W; Pawłowski L
Pharmazie; 2000 Dec; 55(12):917-8. PubMed ID: 11189867
[TBL] [Abstract][Full Text] [Related]
12. Accelerated conditions for stability assessment of bulk and formulated cefaclor monohydrate.
Olsen BA; Perry FM; Snorek SV; Lewellen PL
Pharm Dev Technol; 1997 Nov; 2(4):303-12. PubMed ID: 9552459
[TBL] [Abstract][Full Text] [Related]
13. Solid-state stability studies of faropenem based on chromatography, spectroscopy and theoretical analysis.
Cielecka-Piontek J; Lewandowska K; Barszcz B; Czartek A
Drug Dev Ind Pharm; 2014 Jan; 40(1):136-43. PubMed ID: 23350724
[TBL] [Abstract][Full Text] [Related]
14. The stability of quinapril hydrochloride--a mixture of amorphous and crystalline forms (QHCl-AC)--in solid phase.
Stanisz B
Acta Pol Pharm; 2003; 60(6):443-9. PubMed ID: 15080591
[TBL] [Abstract][Full Text] [Related]
15. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of diltiazem hydrochloride in solid phase.
Muszalska I; Siakowski M
Acta Pol Pharm; 2003; 60(1):27-30. PubMed ID: 12848364
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of degradation of quinapril hydrochloride in tablets.
Stanisz B
Pharmazie; 2003 Apr; 58(4):249-51. PubMed ID: 12749406
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.
Stanisz B; Regulska K
Acta Pol Pharm; 2013; 70(4):737-42. PubMed ID: 23923397
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of cefamandole nafate degradation in solid phase.
Jelińska A; Zajac M; Gostomska J; Szczepaniak M
Farmaco; 2003 Apr; 58(4):309-13. PubMed ID: 12727540
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of omeprazole degradation in solid state.
Popielarz-Brzezińska M
Acta Pol Pharm; 2011; 68(5):753-7. PubMed ID: 21928721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
